Embecta (FRA:JX7) Cash And Cash Equivalents : €276 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Cash And Cash Equivalents?

Embecta's quarterly cash and cash equivalents declined from Sep. 2023 (€305.93 Mil) to Dec. 2023 (€273.91 Mil) but then increased from Dec. 2023 (€273.91 Mil) to Mar. 2024 (€275.82 Mil).

Embecta's annual cash and cash equivalents increased from Sep. 2021 (€0.00 Mil) to Sep. 2022 (€334.21 Mil) but then declined from Sep. 2022 (€334.21 Mil) to Sep. 2023 (€305.93 Mil).

Embecta Cash And Cash Equivalents Historical Data

The historical data trend for Embecta's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Cash And Cash Equivalents Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Cash And Cash Equivalents

334.21

305.93

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial											323.54	292.96	305.93	273.91	275.82

Embecta Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Embecta (FRA:JX7) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Embecta Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Embecta's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (FRA:JX7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines